메뉴 건너뛰기
World Journal of Gastroenterology
Volumn 5, Issue 4, 1999, Pages 330-333
Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles
Author keywords

Hepatocytes permeability; Liver targeting; Polybutylcyanoacrylate nanoparticles; Valaciclovir
Indexed keywords

EID: 0000680936     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v5.i4.330     Document Type: Article
Times cited : (18)
References (9)
  • 2
    • 0027768955 scopus 로고
    • Pharmacokinetics of the acyclovir prodrug valaciclovir after escalating single and multiple dose administration to normal volunteer
    • Stemphen W, Robert BM, Marna D, Thimysta B, Donna MC, Paulo M. Pharmacokinetics of the acyclovir prodrug valaciclovir after escalating single and multiple dose administration to normal volunteer. Clin Pharmacol Ther, 1993,54:595-605
    • (1993) Clin Pharmacol Ther , vol.54 , pp. 595-605
    • Stemphen, W.1    Robert, B.M.2    Marna, D.3    Thimysta, B.4    Donna, M.C.5    Paulo, M.6
  • 3
    • 84889220665 scopus 로고
    • Comparison of acyclovir and interferon in the treatment of chronic hepatitis B
    • Yang SS, Guan MY, Yang LH. Comparison of acyclovir and interferon in the treatment of chronic hepatitis B. Hubei Yixueyuan Zazhi, 1987;8:144-147
    • (1987) Hubei Yixueyuan Zazhi , vol.8 , pp. 144-147
    • Yang, S.S.1    Guan, M.Y.2    Yang, L.H.3
  • 4
    • 84889177790 scopus 로고
    • The effect of acyclovir to chronic active hepatitis B
    • Zhou JL, Xu LZ, Wu H, Min J. The effect of acyclovir to chronic active hepatitis B. Tianjin Yiyao, 1989;17:687-689
    • (1989) Tianjin Yiyao , vol.17 , pp. 687-689
    • Zhou, J.L.1    Xu, L.Z.2    Wu, H.3    Min, J.4
  • 5
    • 0020692647 scopus 로고
    • Acyclovir hepatitis B antigen positive chronic liver disease; inhibition of viral replication and transient renal impairment with iv bolus administration
    • Weller IV, Carreno V, Fowler MJ. Acyclovir hepatitis B antigen positive chronic liver disease; inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother, 1983;11:223-225
    • (1983) J Antimicrob Chemother , vol.11 , pp. 223-225
    • Weller, I.V.1    Carreno, V.2    Fowler, M.J.3
  • 6
    • 0019932364 scopus 로고
    • Preliminary studies of acyclovir in chronic hepatitis B
    • Smith CI, Scullard GH, Gregory PB. Preliminary studies of acyclovir in chronic hepatitis B. Am J Med, 1982;73(1A):267-269
    • (1982) Am J Med , vol.73 , Issue.1 A , pp. 267-269
    • Smith, C.I.1    Scullard, G.H.2    Gregory, P.B.3
  • 7
    • 0028252070 scopus 로고
    • Study on mitoxantrone polybutyl cyanoacrylate nanoparticles
    • Zhang ZR, Liao GT, Hou SX. Study on mitoxantrone polybutyl cyanoacrylate nanoparticles. Zhongguo Yaoxue Xuebao, 1994;29:544 -549
    • (1994) Zhongguo Yaoxue Xuebao , vol.29 , pp. 544-549
    • Zhang, Z.R.1    Liao, G.T.2    Hou, S.X.3
  • 8
    • 0017910704 scopus 로고
    • Nanoparticles: A new colloidal drug delivery system
    • Marty JJ, Oppenheim RC, Speiser P. Nanoparticles: a new colloidal drug delivery system. Pharm Acta Helv, 1978;53:17-23
    • (1978) Pharm Acta Helv , vol.53 , pp. 17-23
    • Marty, J.J.1    Oppenheim, R.C.2    Speiser, P.3
  • 9
    • 0017832535 scopus 로고
    • Nanoparticles and nanocapsules-new dosage forms in the nanometer size range
    • Kreuter J. Nanoparticles and nanocapsules-new dosage forms in the nanometer size range. Pharm Acta Helv, 1978;53:33-39
    • (1978) Pharm Acta Helv , vol.53 , pp. 33-39
    • Kreuter, J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.